Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Comment by NewFanCBDon Sep 17, 2020 11:55am
122 Views
Post# 31574536

RE:RE:RE:<10PPM THC change in CBD

RE:RE:RE:<10PPM THC change in CBD

Ok I have done some homework on this point and there seems to be some confusion here. Cortalex’s bottle label says <10ppm THC (less than 10 parts per million THC) therefore eliminating Health Canada’s requirement for putting a THC warning label on the bottle. 

See below at the bottom, the link to Health Canada’s page discussing the standardized cannabis symbol that under the Cannabis Regulations must appear on the label of all cannabis products that contain THC in a concentration greater than 10 micrograms per gram which is the same as <10ppm.

So, to me, it seems like Cardiol is simply following the Health Canada regulations and by showing that Cortalex is <10ppm THC, it does not require this warning label. 

I believe GW Pharma’s FDA-approved cannabidiol product Epidiolex is 150ppm THC as I just spent time on their site. Bottom line, Cortalex is by far the purest cannabidiol formulation available as far as I know. Hopefully that clears that point up. Go CRDL !!

https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/laws-regulations/regulations-support-cannabis-act/standardized-symbol.html

 


 

<< Previous
Bullboard Posts
Next >>